Chronic consumption of Annona muricata juice triggers and aggravates cerebral tau phosphorylation in wild‐type and MAPT transgenic mice

In the pathogenesis of tauopathies, genetic and environmental factors have been identified. While familial clustering led to the identification of mutations in MAPT encoding the microtubule‐associated protein tau, the high incidence of a sporadic tauopathy endemic in Guadeloupe was linked to the plant‐derived mitochondrial complex I inhibitor annonacin. The interaction of both factors was studied in the present work in a realistic paradigm over a period of 12 months. Mice over‐expressing either human wild‐type tau or R406W mutant tau as well as non‐transgenic mice received either regular drinking water or commercially available tropical fruit juice made of soursop (Annona muricata L.) as dietary source of neurotoxins. HPLC‐MS analysis of this juice identified several Annonaceous acetogenins, mainly annonacin (16.2 mg/L), and 41 isoquinoline alkaloids (18.0 mg/L, mainly asimilobine and reticuline). After 12 month of juice consumption, several brain regions showed an increased number of neurons with phosphorylated tau in the somatodendritic compartment of R406W mice and, to a much lesser extent, of non‐transgenic mice and mice over‐expressing human wild‐type tau. Moreover, juice drinking was associated with a reduction in synaptophysin immunoreactivity, as well as an increase in 3‐nitrotyrosine (3NT) reactivity in all three genotypes. The increase in 3NT suggests that Annona muricata juice promotes the generation of reactive nitrogen species. This study provides first experimental evidence that long‐lasting oral ingestion of a widely consumed environmental factor can induce somatodendritic accumulation of hyperphosphorylated tau in mice expressing rodent or human wild‐type tau, and can accelerate tau pathology in R406W‐MAPT transgenic mice.

[1]  S. Shim,et al.  Immunomodulatory Efficacy of Standardized Annona muricata (Graviola) Leaf Extract via Activation of Mitogen-Activated Protein Kinase Pathways in RAW 264.7 Macrophages , 2016, Evidence-based complementary and alternative medicine : eCAM.

[2]  S. Bandyopadhyay,et al.  Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators , 2016, Molecular Neurobiology.

[3]  D. Touboul,et al.  Method development for quantification of the environmental neurotoxin annonacin in Rat plasma by UPLC-MS/MS and application to a pharmacokinetic study. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  F. Ghorbani,et al.  Homozygous MAPT R406W mutation causing FTDP phenotype: A unique instance of a unique mutation. , 2015, Gene.

[5]  I. Ferrer,et al.  High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents. , 2015, Biochimica et biophysica acta.

[6]  Lynn A. Hyde,et al.  Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology , 2015, Molecular Neurodegeneration.

[7]  Francisco Melo,et al.  Andrographolide activates the canonical Wnt signalling pathway by a mechanism that implicates the non-ATP competitive inhibition of GSK-3β: autoregulation of GSK-3β in vivo. , 2015, The Biochemical journal.

[8]  C. Dickey,et al.  Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy , 2015, Acta neuropathologica communications.

[9]  W. Oertel,et al.  Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice , 2014, PloS one.

[10]  D. Touboul,et al.  Quantification of annonacin in Rat plasma: Application to pharmacokinetic study , 2014 .

[11]  W. Oertel,et al.  Annonacin, a natural lipophilic mitochondrial complex I inhibitor, increases phosphorylation of tau in the brain of FTDP-17 transgenic mice , 2014, Experimental Neurology.

[12]  T. Révész,et al.  The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons , 2013, Acta Neuropathologica.

[13]  Michel Goedert,et al.  Tau pathology and neurodegeneration , 2013, The Lancet Neurology.

[14]  D. Touboul,et al.  Comprehensive characterization of Annonaceous acetogenins within a complex extract by HPLC-ESI-LTQ-Orbitrap® using post-column lithium infusion. , 2012, Journal of mass spectrometry : JMS.

[15]  D. Touboul,et al.  Annonaceous acetogenins within extracts: dereplication by HPLC-ESI-LTQ-Orbitrap® using post-column lithium infusion , 2012 .

[16]  M. Singh,et al.  A Current Review of Cypermethrin-Induced Neurotoxicity and Nigrostriatal Dopaminergic Neurodegeneration , 2012, Current neuropharmacology.

[17]  S. Ohta,et al.  Annonamine, a new aporphine alkaloid from the leaves of Annona muricata. , 2012, Chemical & pharmaceutical bulletin.

[18]  C. Zhong,et al.  Exposure to Pyrithiamine Increases β-Amyloid Accumulation, Tau Hyperphosphorylation, and Glycogen Synthase Kinase-3 Activity in the Brain , 2011, Neurotoxicity Research.

[19]  G. Drewes,et al.  The frontotemporal dementia mutation R406W blocks tau’s interaction with the membrane in an annexin A2–dependent manner , 2011, The Journal of cell biology.

[20]  K. Ashe,et al.  Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration , 2010, Neuron.

[21]  V. Guérineau,et al.  MALDI-TOF MS Profiling of Annonaceous Acetogenins in Annona muricata Products for Human Consumption , 2009, Molecules.

[22]  M. Ruberg,et al.  Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies , 2009, Experimental Neurology.

[23]  G. Waldemar,et al.  Genetic testing in familial AD and FTD: Mutation and phenotype spectrum in a Danish cohort , 2009, Clinical genetics.

[24]  J. Kordower,et al.  Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease , 2009, Neurobiology of Disease.

[25]  Baochang Cai,et al.  Supercritical fluid CO2 extraction and simultaneous determination of eight annonaceous acetogenins in Annona genus plant seeds by HPLC-DAD method. , 2009, Journal of pharmaceutical and biomedical analysis.

[26]  A. Miyashita,et al.  Mutational Analysis in Early-Onset Familial Dementia in the Japanese Population , 2008, Dementia and Geriatric Cognitive Disorders.

[27]  J. Stokholm,et al.  Alzheimer disease‐like clinical phenotype in a family with FTDP‐17 caused by a MAPT R406W mutation , 2008, European journal of neurology.

[28]  C. Mactutus,et al.  Differential long‐term neurotoxicity of HIV‐1 proteins in the rat hippocampal formation: A design‐based stereological study , 2008, Hippocampus.

[29]  S. Nelson,et al.  Layer V neurons in mouse cortex projecting to different targets have distinct physiological properties. , 2007, Journal of neurophysiology.

[30]  E. Hirsch,et al.  Annonacin, a Natural Mitochondrial Complex I Inhibitor, Causes Tau Pathology in Cultured Neurons , 2007, The Journal of Neuroscience.

[31]  B. Dubois,et al.  Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? , 2007, Brain : a journal of neurology.

[32]  Bin Zhang,et al.  Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.

[33]  Weidong Zhang,et al.  Characterization of isoquinoline alkaloids, diterpenoids and steroids in the Chinese herb Jin-Guo-Lan (Tinospora sagittata and Tinospora capillipes) by high-performance liquid chromatography/electrospray ionization with multistage mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.

[34]  D. Timm,et al.  Pyrithiamine as a Substrate for Thiamine Pyrophosphokinase* , 2006, Journal of Biological Chemistry.

[35]  M. Ruberg,et al.  Quantification of acetogenins in Annona muricata linked to atypical parkinsonism in guadeloupe , 2005, Movement disorders : official journal of the Movement Disorder Society.

[36]  Jean Féger,et al.  The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy , 2005, Journal of neurochemistry.

[37]  B. Hyman,et al.  Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.

[38]  R. Ravid,et al.  Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.

[39]  G. Roué,et al.  Annonaceous Acetogenins: The Hydroxyl Groups and THF Rings Are Crucial Structural Elements for Targeting the Mitochondria, Demonstration with the Synthesis of Fluorescent Squamocin Analogues , 2005, Chembiochem : a European journal of chemical biology.

[40]  M. Zenk,et al.  Analysis of Benzylisoquinoline-Type Alkaloids by Electrospray Tandem Mass Spectrometry and Atmospheric Pressure Photoionization , 2005, European journal of mass spectrometry.

[41]  A. Bermejo,et al.  Acetogenins from Annonaceae: recent progress in isolation, synthesis and mechanisms of action. , 2005, Natural product reports.

[42]  Koji Abe,et al.  Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice. , 2005, The American journal of pathology.

[43]  H. Hara,et al.  Detection and determination of reticuline and N-methylcoculaurine in the Annonaceae family using liquid chromatography-tandem mass spectrometry. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[44]  L. Lannfelt,et al.  The Tau R406W Mutation Causes Progressive Presenile Dementia with Bitemporal Atrophy , 2004, Dementia and Geriatric Cognitive Disorders.

[45]  E. Larsson,et al.  Familial Presenile Dementia with Bitemporal Atrophy , 2004, Dementia and Geriatric Cognitive Disorders.

[46]  Bin Zhang,et al.  Retarded Axonal Transport of R406W Mutant Tau in Transgenic Mice with a Neurodegenerative Tauopathy , 2004, The Journal of Neuroscience.

[47]  Jean-Louis Habib Jiwan,et al.  Key fragmentation patterns of aporphine alkaloids by electrospray ionization with multistage mass spectrometry. , 2004, Rapid communications in mass spectrometry : RCM.

[48]  Jean Féger,et al.  Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe , 2003, Journal of neurochemistry.

[49]  A. Goate,et al.  Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western Europe , 2003, Human mutation.

[50]  P Champy,et al.  The mitochondrial complex i inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism , 2003, Neuroscience.

[51]  J. Paul Robinson,et al.  Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production* , 2003, The Journal of Biological Chemistry.

[52]  T. Hashikawa,et al.  Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  T. Nagatsu Amine-related neurotoxins in Parkinson's disease: past, present, and future. , 2002, Neurotoxicology and teratology.

[54]  Charles Duyckaerts,et al.  Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. , 2002, Brain : a journal of neurology.

[55]  Joshua M. Shulman,et al.  Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles , 2001, Science.

[56]  R. Ravid,et al.  Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation. , 2001, The American journal of pathology.

[57]  M. Goedert,et al.  Reduced Binding of Protein Phosphatase 2A to Tau Protein with Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 Mutations , 2000, Journal of neurochemistry.

[58]  Patrick R Hof,et al.  Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach , 2000, Journal of Chemical Neuroanatomy.

[59]  J. Ávila,et al.  The FTDP‐17‐Linked Mutation R406W Abolishes the Interaction of Phosphorylated Tau with Microtubules , 2000, Journal of neurochemistry.

[60]  W. Kamphorst,et al.  Phenotypic variation in hereditary frontotemporal dementia with tau mutations , 1999, Annals of neurology.

[61]  Alexis Elbaz,et al.  Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study , 1999, The Lancet.

[62]  G. Schellenberg,et al.  A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) , 1999, Brain : a journal of neurology.

[63]  C. Duijn,et al.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. , 1999, American journal of human genetics.

[64]  M. Goedert,et al.  Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly , 1998, FEBS letters.

[65]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[66]  M. L. Schmidt,et al.  Autosomal dominant dementia with widespread neurofibrillary tangles , 1997, Annals of neurology.

[67]  T. Nagatsu Isoquinoline neurotoxins in the brain and Parkinson's disease , 1997, Neuroscience Research.

[68]  Philip R. Cohen,et al.  Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases , 1997, FEBS letters.

[69]  N L Foster,et al.  Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference , 1997, Annals of neurology.

[70]  G. Vauquelin,et al.  Screening of medicinal plants from Suriname for 5-HT(1A) ligands: Bioactive isoquinoline alkaloids from the fruit of Annona muricata. , 1997, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[71]  N. Oberlies,et al.  The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells. , 1997, Cancer letters.

[72]  P. Forgacs,et al.  [Alkaloids of Annonaceae. XXIX. Alkaloids of Annona muricata]. , 1981, Planta medica.

[73]  R. Swerdlow,et al.  Mitochondria, Cybrids, Aging, and Alzheimer's Disease. , 2017, Progress in molecular biology and translational science.

[74]  N. Bhat,et al.  Increased tau phosphorylation and impaired brain insulin/IGF signaling in mice fed a high fat/high cholesterol diet. , 2013, Journal of Alzheimer's disease : JAD.

[75]  S. C. Smith,et al.  Annonacin in Asimina triloba fruit: implication for neurotoxicity. , 2012, Neurotoxicology.

[76]  C. Geula,et al.  Selective tau tyrosine nitration in non-AD tauopathies , 2011, Acta Neuropathologica.

[77]  Merle Ruberg,et al.  Toxicity of Annonaceae for dopaminergic neurons: Potential role in atypical parkinsonism in Guadeloupe , 2002, Movement disorders : official journal of the Movement Disorder Society.

[78]  P. K. Bhaumik,et al.  The phytochemistry of the annonaceae , 1980 .

[79]  Glycogen Synthase Kinase 3 (cid:1) Phosphorylates Tau at Both Primed and Unprimed Sites , 2022 .

[80]  The FASEB Journal • Research Communication Mitochondrial signals initiate the activation of c-Jun N-terminal kinase (JNK) by hypoxia-reoxygenation , 2022 .